Supporting oncology professionals through education

The content on this site is intended for healthcare professionals only

Videos [2258]
News [4607]
Articles [190]
Editorials [8]
Conferences [135]
elearning [9]
IEO commended as a center of excellence in providing treatment for international patients
IEO commended as a center of excellence in providing treatment for international patients
EHA 2015: A new targeted combination therapy with potential to eliminate relapsed chronic lymphocytic leukaemia
EHA 2015: A new targeted combination therapy with potential to eliminate relapsed chronic lymphocytic leukaemia
Francophone Palliative Care Initiators’ Course provided a holistic learning experience at Hospice Africa Uganda
Francophone Palliative Care Initiators’ Course provided a holistic learning experience at Hospice Africa Uganda
'Cancer plans must put the patient at the centre of treatment’, conference hears
'Cancer plans must put the patient at the centre of treatment’, conference hears
NICE preliminary decision to remove olaparib for ovarian cancer patients with BRCA gene mutations
NICE preliminary decision to remove olaparib for ovarian cancer patients with BRCA gene mutations
ASCO 2015: MEDI4736 tremelimumab combo shows activity in NSCLC
ASCO 2015: MEDI4736 tremelimumab combo shows activity in NSCLC
ASCO 2015: Obinutuzumab doubles remission duration in patients with relapsed, indolent non-hodgkin lymphoma
ASCO 2015: Obinutuzumab doubles remission duration in patients with relapsed, indolent non-hodgkin lymphoma
ASCO 2015: New ibrutinib combination regimen shows substantial benefits in relapsed chronic lymphocytic leukaemia
ASCO 2015: New ibrutinib combination regimen shows substantial benefits in relapsed chronic lymphocytic leukaemia
ASCO 2015: Novel JAK inhibitor pacritinib proves effective for easing symptoms of myelofibrosis
ASCO 2015: Novel JAK inhibitor pacritinib proves effective for easing symptoms of myelofibrosis
ASCO 2015: Pembrolizumab shows promising activity against head and neck cancer
ASCO 2015: Pembrolizumab shows promising activity against head and neck cancer

More from ecancer

Register with ecancer to receive our newsletter

Register here

Explore patient resources at ecancerpatient

Visit site

Find out more about ecancer and the work we do

About ecancer

Support ecancer's work by making a donation